Mara Joseph Anthony Jr reported option exercise involving 25,000 derivative units of Vericel Corp at $0.00 for $0 on Nov 9, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Financial Officer
Chief Financial Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
25,000Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
135,000Direct
Trade date
Nov 9, 2026Option exercise
Filed
Nov 12, 2026, 8:04 PM ET4-day reporting delay
Accession
0001140361-26-043494Code M · Transaction 400031
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Sell25,000$58.26−$1,456,500Trade 400028
Nov 11, 2026Sell8$59.75−$478Trade 400030
Nov 11, 2026Option exercise8$0.00$0Trade 400032
Nov 9, 2026Option exercise25,000$43.63$1,090,750Trade 400027
Nov 11, 2026Option exercise8$43.63$349.04Trade 400029
6 transaction rows in this filing. Joint filers share the same rows.

VCEL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
VCEL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −30%1w ago −25%1d ago −4.9%
Returns since7d30d90d180d1y

Footnotes in full

F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. F3: These options, representing the right to purchase 160,000 shares, became exercisable on January 25, 2022, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.